Back to Browse Journals » Open Access Emergency Medicine » Volume 5

Auto-transfusion tourniquets: the next evolution of tourniquets

Authors Tang DH, Olesnicky BT, Eby MW, Heiskell LE

Published Date December 2013 Volume 2013:5 Pages 29—32

DOI http://dx.doi.org/10.2147/OAEM.S39042

Received 11 October 2012, Accepted 27 August 2013, Published 6 December 2013

David H Tang,1,2,3 Bohdan T Olesnicky,1,3 Michael W Eby,1,4 Lawrence E Heiskell1,5

1International School of Tactical Medicine, Palm Springs, CA, USA; 2Eisenhower Medical Center, Rancho Mirage, CA, USA; 3High Desert Medical Center, Joshua Tree, CA, USA; 4Veterans Administration Loma Linda Healthcare System, Loma Linda, CA, USA; 5Fallbrook Community Hospital, Fallbrook, CA, USA

Abstract: In this article, we discuss the relationship between hemorrhagic shock and the pathophysiology of shock using conventional tourniquets. We will focus on corollary benefits with the use of HemaClear®, a self-contained, sterile, exsanguinating auto-transfusion tourniquet. This discussion will demonstrate that the use of auto-transfusion tourniquets is a practical evidence-based approach in fluid resuscitation: it shortens the duration of shock after hemorrhage and trauma compared with conventional tourniquets. Emphasis is placed on the use of the HemaClear® as an alternative fluid resuscitation tool which is more efficient in the battlefield, pre-hospital and in-hospital settings.

Keywords: auto-transfusion tourniquet, field exsanguination, hemorrhagic shock, tourniquet, perfusion requirement, HemaClear® ATT

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Current trends in biobanking for rare diseases: a review [Corrigendum]

Graham CE, Molster C, Baynam GS, Bushby K, Hansson M, Mascalzoni D, Kole A, Mora M, Monaco L, Bellgard M, Carpentieri D, Posada M, Riess O, Rubinstein YR, Schaefer F, Taruscio D, Terry SF, Zatloukal K, Knoppers B, Lochmüller H, Dawkins HJS

Journal of Biorepository Science for Applied Medicine 2015, 3:1-2

Published Date: 20 March 2015

Non-invasive prenatal testing: a review of international implementation and challenges

Allyse M, Minear MA, Berson E, Sridhar S, Rote M, Hung A, Chandrasekharan S

International Journal of Women's Health 2015, 7:113-126

Published Date: 16 January 2015

Lower irritation microemulsion-based rotigotine gel: formulation optimization and in vitro and in vivo studies

Wang Z, Mu HJ, Zhang XM, Ma PK, Lian SN, Zhang FP, Chu SY, Zhang WW, Wang AP, Wang WY, Sun KX

International Journal of Nanomedicine 2015, 10:633-644

Published Date: 14 January 2015

Disease burden and patient reported outcomes among patients with moderate to severe psoriasis: an ethnography study

Narayanan S, Guyatt V, Franceschetti A, Hautamaki EL

Psoriasis: Targets and Therapy 2015, 5:1-7

Published Date: 23 December 2014

Using registries to identify type 2 diabetes patients

Thomsen RW, Sørensen HT

Clinical Epidemiology 2015, 7:1-3

Published Date: 18 December 2014